RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties November 20, 2025j3ff1
RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement November 19, 2025j3ff1
RespireRx Pharmaceuticals Inc. Announces Commencement of Rule 506(c) Private Placement November 18, 2025j3ff1